Equity Prepayment Facility of up to £5 mill... | 03-Aug-2023 | 07:00 | RNS |
Sareum Announces Two New Granted Patents | 26-Jun-2023 | 07:00 | RNS |
Dosing commences in Phase 1a trial of SDC-801 | 06-Jun-2023 | 07:00 | RNS |
Phase 1a clinical trial for SDC-1801 | 18-May-2023 | 07:00 | RNS |
Approval to initiate Phase 1 clinical trial | 05-May-2023 | 09:20 | RNS |
Half-Year Report | 22-Mar-2023 | 07:00 | RNS |
Update on SDC-1801 | 15-Mar-2023 | 07:01 | RNS |
Notice of Half-Year Results | 15-Mar-2023 | 07:00 | RNS |
Update on SRA737 | 06-Mar-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 29-Dec-2022 | 15:14 | RNS |
Results of AGM | 16-Dec-2022 | 15:29 | RNS |
AGM Statement | 16-Dec-2022 | 07:00 | RNS |
Notice of AGM, Annual Report and Accounts | 24-Nov-2022 | 07:00 | RNS |
Second Price Monitoring Extn | 09-Nov-2022 | 16:41 | RNS |
Price Monitoring Extension | 09-Nov-2022 | 16:35 | RNS |
Currency | UK Pounds |
Share Price | 43.50p |
Change Today | 3.00p |
% Change | 7.41 % |
52 Week High | 135.00 |
52 Week Low | 10.25 |
Volume | 781,084 |
Shares Issued | 106.84m |
Market Cap | £46.47m |
RiskGrade | 594 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
15:30 | 60,000 @ 44.00p |
15:35 | 40,000 @ 44.00p |
16:26 | 20,000 @ 43.00p |
16:25 | 500 @ 43.00p |
16:23 | 8,895 @ 43.10p |
You are here: research